Back to Search
TERRY MOODY, D.O.
D.O.
Student in an Organized Health Care Education/Training Program
NPI: 1154093169Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
PMID 19628293·Lung Cancer·2010
7-preclinical
Common and dissociable prefrontal loci associated with component mechanisms of analogical reasoning.
PMID 19549622·Cereb Cortex·2010
8-other
Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
PMID 19463875·Peptides·2009
7-preclinical
Your brain on Google: patterns of cerebral activation during internet searching.
PMID 19155745·Am J Geriatr Psychiatry·2009
8-other
Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.
PMID 19276279·Clin Cancer Res·2009
8-other
Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states.
PMID 18185064·Curr Opin Endocrinol Diabetes Obes·2008
6-review
Bombesin marine toxin conjugates inhibit the growth of lung cancer cells.
PMID 18336841·Life Sci·2008
7-preclinical
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.
PMID 17580098·Peptides·2007
7-preclinical
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.
PMID 17351657·Br J Pharmacol·2007
7-preclinical
Vasoactive intestinal peptide receptors: a molecular target in breast and lung cancer.
PMID 17430173·Curr Pharm Des·2007
6-review
Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.
PMID 17567944·Ann N Y Acad Sci·2007
7-preclinical
In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
PMID 16766720·J Pharmacol Exp Ther·2006
7-preclinical
Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.
PMID 16691010·J Mol Neurosci·2006
7-preclinical
Gastrointestinal hormones cause rapid c-Met receptor down-regulation by a novel mechanism involving clathrin-mediated endocytosis and a lysosome-dependent mechanism.
PMID 17035232·J Biol Chem·2006
7-preclinical
Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo.
PMID 15750618·Oncogene·2005
8-other
Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
PMID 15867218·Clin Cancer Res·2005
4-observational
NIH deltanoids meeting on Vitamin D and cancer. Conclusion and strategic options.
PMID 16043351·J Steroid Biochem Mol Biol·2005
8-other
Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells.
PMID 16112393·Peptides·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1400 8TH AVE
FORT WORTH, TX 76104 - Phone
- (817) 922-1535
Quick Facts
- NPI
- 1154093169
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile